Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG‐ACRIN Cancer Research Group (E1302) is a research paper published in Cancer Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: UG1CA189828
National Cancer Institute
Grant: UG1CA233196
National Cancer Institute
Grant: UG1CA233320
National Cancer Institute
Grant: UG1CA233341
NCI NIH HHS
Grant: U10 CA180820
NCI NIH HHS
Grant: T32 CA193193
NCI NIH HHS
Grant: U10 CA180794
National Institutes of Health
Grant: 5UG1CA233196-03
Johns Hopkins University NCTN Lead Academic Site Program
National Institutes of Health
Grant: 5T32CA193193-10
Behavioral and Psychosocial Research Training in Cancer Prevention and Control
National Institutes of Health
Grant: 5UG1CA233341-05
Sidney Kimmel Cancer Center LAPS Institutional Collaboration
National Institutes of Health
Grant: 5UG1CA189828-10
ECOG-ACRIN NCORP Research Base
National Institutes of Health
Grant: 5UG1CA233320-02
Northwestern University Lead Academic Participating Site
FWCI
0.64
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals